🇺🇸 VTRS — Viatris Inc.

Salud Compra
← Volver

Precio actual

19,91 USD

Máx. histórico

76,06

4214 días

Split 3:2 del 09/10/2003

Caída desde máximo

-73,82%

Rango 52 semanas

9,92 – 19,96

Variación hoy

+4,96%

Cierre anterior

18,97

Rango de hoy

18,80 – 19,94

Volumen hoy

14.437.429

Peor caída histórica

-88,75%

24/04/2015 → 10/04/2025

Aún sin recuperar

Volatilidad anualizada ⓘ

44,79%

Información
Nombre completo
Viatris Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
30.000
PER ⓘ
—
Dividend yield
2,53% (puede no estar actualizado)
Precio objetivo analistas
20,00 USD (puede no estar actualizado)
Primera cotización
17/03/1980
Precio actualizado
hace 19 horas
Sobre la empresa

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Dividendos repartidos Total últimos 12 meses: 0,4800 USD · Yield: 2,41%
Fecha de pago Importe por participación
21/08/2026 0,1200 USD
22/05/2026 0,1200 USD
09/03/2026 0,1200 USD
24/11/2025 0,1200 USD
22/08/2025 0,1200 USD
23/05/2025 0,1200 USD
10/03/2025 0,1200 USD
22/11/2024 0,1200 USD
23/08/2024 0,1200 USD
23/05/2024 0,1200 USD
08/03/2024 0,1200 USD
22/11/2023 0,1200 USD
23/08/2023 0,1200 USD
23/05/2023 0,1200 USD
08/03/2023 0,1200 USD
Splits Registrados en el histórico de precios
Fecha Ratio
09/10/2003 3:2
28/01/2003 3:2
16/08/1995 3:2
03/08/1992 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/05/2011 23,92 24,23 23,71 24,04 -0,17% 2,17% 5.200.000
04/05/2011 23,98 24,28 23,73 24,08 -0,62% 2,29% 7.817.800
03/05/2011 24,59 24,68 23,84 24,23 -2,46% 3,42% 13.000.000
02/05/2011 25,13 25,24 24,73 24,84 -0,32% 2,03% 7.742.200
29/04/2011 24,95 25,07 24,79 24,92 -0,36% 1,12% 6.765.900
28/04/2011 25,15 25,21 24,93 25,01 -0,87% 1,11% 5.400.000
27/04/2011 25,37 25,46 25,02 25,23 +0,12% 1,73% 6.146.400
26/04/2011 25,03 25,35 24,84 25,20 +0,72% 2,04% 7.300.000
25/04/2011 24,85 25,04 24,66 25,02 +1,46% 1,53% 6.145.200
21/04/2011 24,74 24,93 24,56 24,66 -0,52% 1,50% 10.277.600
20/04/2011 24,10 25,10 24,10 24,79 +3,21% 4,15% 17.284.600
19/04/2011 23,55 24,06 22,96 24,02 +2,30% 4,67% 11.342.900
18/04/2011 23,69 23,75 23,26 23,48 -1,72% 2,07% 4.957.900
15/04/2011 23,32 23,98 23,09 23,89 +3,11% 3,82% 7.636.400
14/04/2011 23,31 23,39 23,10 23,17 -1,36% 1,24% 5.043.700
13/04/2011 23,50 23,62 23,35 23,49 +0,04% 1,15% 2.588.300
12/04/2011 23,50 23,66 23,32 23,48 -0,51% 1,45% 2.241.900
11/04/2011 23,50 23,79 23,50 23,60 +0,68% 1,23% 4.883.400
08/04/2011 23,37 23,50 23,09 23,44 +0,86% 1,75% 4.499.200
07/04/2011 23,18 23,44 23,08 23,24 +0,17% 1,55% 3.183.700
06/04/2011 23,47 23,56 22,96 23,20 -0,56% 2,56% 4.288.800
05/04/2011 23,27 23,46 23,08 23,33 -0,17% 1,63% 4.164.400
04/04/2011 23,21 23,50 23,15 23,37 +0,60% 1,51% 3.204.000
01/04/2011 22,88 23,23 22,60 23,23 +2,52% 2,75% 5.910.200
31/03/2011 22,81 22,86 22,49 22,66 -0,53% 1,62% 3.993.800
30/03/2011 22,49 22,88 22,47 22,78 +1,47% 1,82% 4.962.500
29/03/2011 22,16 22,45 22,10 22,45 +1,49% 1,58% 3.727.400
28/03/2011 22,36 22,42 22,12 22,12 -0,85% 1,34% 3.568.100
25/03/2011 22,32 22,49 22,08 22,31 -0,13% 1,84% 4.393.500
24/03/2011 22,05 22,42 21,78 22,34 +1,73% 2,90% 4.545.300